Yangzhenhua 851

MENU

A Non-Probiotic Fermented Soy Product Reduces Total and LDL Cholesterol: A Randomized Controlled Crossover Trial

2021-02-24

A Non-Probiotic Fermented Soy Product Reduces Total and LDL Cholesterol: A Randomized Controlled Crossover Trial

http://www.mdpi.com/journal/nutrients

Previous

Efficacy and toxicity studies on unique branched chain fatty acids and their derivatives as potential anticancer agents

Next

Previous

Efficacy and toxicity studies on unique branched chain fatty acids and their derivatives as potential anticancer agents

Next

Categories

Categories

Researchtheme on anti-aging and others

Researchtheme on cancer

Researchtheme on ALS

Research theme on improvement of immunity

Recent posts

Effects of Fermented Soy on Cognition in Older Adults

2025-09-30

The fermented soy beverage Q-CAN® plus induces beneficial changes in the oral and intestinal microbiome

2025-06-03

Q-Can PRELIMINARY REPORT

2025-06-03

Effect of the Fermented Soy Q-CAN® Product on Biomarkers of Inflammation and Oxidation in Adults with Cardiovascular Risk, and Canonical Correlations between the Inflammation Biomarkers and Blood Lipids

2025-06-03

Fermented Soy Beverage Q-CAN Plus Consumption Improves Serum Cholesterol and Cytokines

2025-06-03

Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational Registration

2025-06-03

Copyright © Fujian Yang Zhenhua 851 Bio-Science Co., Ltd Powered by www.300.cn

Business Licence SEO